Bio Path | BPTH - Current Liabilities


Bio Path reported $8.68M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
Baxter International USD 2.97B 805M Dec/2025
Bio Path USD 8.68M 819K Sep/2025
Cipla INR 62.97B 8.13B Sep/2025
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 22.57M 2.29M Dec/2025
CSL USD 4.61B 207M Dec/2025
Grifols EUR 2.37B 156.97M Dec/2025
Karyopharm Therapeutics USD 92.06M 4.9M Dec/2025